Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Anixa Biosciences Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 66 | +1 |
| Shares | 5.35M | 42.0K | 5.41M | +106.9K (+2.0%) |
| Value | $17.6M | $138.7K | $17.9M | +$362.6K (+2.1%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Anixa Biosciences Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 20,775 | $66.0K | 0.00% |
| Pensionmark Financial Group, LLC | 14,619 | $48.2K | 0.00% |
| Concorde Asset Management, LLC | 13,969 | $45.6K | 0.02% |
| Simplex Trading, LLC | 8,184 | $27.0K | 0.00% |
| Jones Financial Companies LLLP | 2,036 | $6.92K | 0.00% |
| Advisory Services Network, LLC | 400 | $1.32K | 0.00% |
| Barclays PLC | 9 | $30 | 0.00% |
| Citigroup Inc | 1 | $3 | 0.00% |
Sold out (7)
Institutions that held Anixa Biosciences Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 41,800 | $137.9K |
| Bradley Foster & Sargent Inc | 20,263 | $66.9K |
| Colony Group, LLC | 18,243 | $60.2K |
| Millennium Management LLC | 10,582 | $34.9K |
| Livelsberger Financial Advisory | 1,634 | $5.39K |
| Raymond James Financial Inc | 1,260 | $4.16K |
| Barrett & Company, Inc. | 80 | $264 |
Not filed for Q3 2025 yet (1)
Institutions that held Anixa Biosciences Inc at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Tyler-Stone Wealth Management | 42,016 | $138.7K |